Acumen Pharmaceuticals, Inc. (ABOS)
0.2432
+0.02
(+8.81%)
USD |
NASDAQ |
Nov 09, 11:47
Acumen Pharmaceuticals Market Cap : 17.59M for Nov. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 06, 2026 | 16.17M |
| November 05, 2026 | 15.46M |
| November 04, 2026 | 15.64M |
| November 03, 2026 | 16.95M |
| November 02, 2026 | 17.34M |
| October 30, 2026 | 15.20M |
| October 29, 2026 | 165.63M |
| October 28, 2026 | 172.14M |
| October 27, 2026 | 163.46M |
| October 26, 2026 | 164.18M |
| October 23, 2026 | 143.21M |
| October 22, 2026 | 148.99M |
| October 21, 2026 | 146.82M |
| October 20, 2026 | 145.71M |
| October 19, 2026 | 128.00M |
| October 16, 2026 | 122.21M |
| October 15, 2026 | 120.77M |
| October 14, 2026 | 126.19M |
| October 13, 2026 | 131.25M |
| October 12, 2026 | 146.08M |
| October 09, 2026 | 154.75M |
| October 08, 2026 | 151.86M |
| October 07, 2026 | 151.86M |
| October 06, 2026 | 146.80M |
| October 05, 2026 | 154.03M |
| Date | Value |
|---|---|
| October 02, 2026 | 147.52M |
| October 01, 2026 | 149.69M |
| September 30, 2026 | 160.54M |
| September 29, 2026 | 162.35M |
| September 28, 2026 | 166.32M |
| September 25, 2026 | 161.98M |
| September 24, 2026 | 161.62M |
| September 23, 2026 | 166.69M |
| September 22, 2026 | 191.63M |
| September 21, 2026 | 187.30M |
| September 18, 2026 | 191.63M |
| September 17, 2026 | 185.85M |
| September 16, 2026 | 188.74M |
| September 15, 2026 | 208.99M |
| September 14, 2026 | 201.76M |
| September 11, 2026 | 211.16M |
| September 10, 2026 | 206.82M |
| September 09, 2026 | 206.10M |
| September 08, 2026 | 228.51M |
| September 04, 2026 | 229.96M |
| September 03, 2026 | 223.45M |
| September 02, 2026 | 224.18M |
| September 01, 2026 | 211.16M |
| August 31, 2026 | 206.10M |
| August 28, 2026 | 211.16M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.687B |
| Alnylam Pharmaceuticals, Inc. | 20.82B |
| Anika Therapeutics, Inc. | 196.60M |
| Savara, Inc. | 1.017B |
| Vericel Corp. | 2.935B |
Market Cap Related Metrics
| Price to Book Value | 0.5083 |
| Price | 0.2432 |
| Earnings Yield | -635.9% |